维普中文期刊产品整合服务
54篇 您的检索式:作者名="Zegeling"
    题名 作者 年代 出处 被引量
1A predator-prey model with Ivlev's functions response显示文摘Kooij R E Zegeling A 1996Journal of Mathematical Analysis and Applications1996,198,5:1
2Percutaneous nephrostomy: comparison of sonographic and fluoroscopic guidance显示文摘ZEGEL HG POLLACK M KOOLPE H 1981Am J Radiol1981,137,:1
3Percutaneous nephrostomy: comparison of sonographic and fluoroscopic guidance显示文摘Zegel HG Pollack HM Banner MC 1981Am J Roentgenol1981,137,5:1
4Qualitative properties of two-dimensional predator-prey system显示文摘KOOIJ R E ZEGELING A 1997Nonlinear Analysis TMA1997,29,6:1
5A predator-prey model with Ivlev's function response 显示文摘KKKJI R E ZEGELING A 1996J Math Anal Appl1996,198,2:1
6A predator-prey model with Ivlev's functional response显示文摘Kooij R E Zegeling A 1996J Math Anal Appl1996,198,:1
7A 2-year phase II study with 1-year of follow-up of risedronate(NE-58O95)in postmenopausal osteoporosis显示文摘Clemmesen B Ravn P Zegels B 1997Osteoporosis Int1997,7,:1
8Qualitative properties of two-dimensional predator-prey systems显示文摘Kooij R E Zegeling A 1997Nonl Anal TMA1997,29,2:1
9A 2-year phase II study with 1-year of follow-up of risedronate(NE-58095) in postmenopausal osteoporosis显示文摘Clemmesen B Ravn P Zegels B 1997Osteoporosis Int1997,7,5:1
10A 2-year phase H study with 1-year of follow-up of risedronate(NE-58095)in postm- enopausal osteoporO6is显示文摘Clemmesen B Ravn P Zegels B 1997Osteoporosis Int1997,7,:1
11Reduction in PINP,a marker of bone metabolism,with raloxifene treatment and its relationship with vertebral fracture risk显示文摘RECINSTER J Y SARKAR S ZEGELS B 2004Bone2004,34,:1
12A Qualitative Properties of Tow-dimen Sional Predator-Prey systems显示文摘Kooij R E Zegeling 1997Nonlinear Analysis Theory Methods and Applications an International Mulfidiseaplinary Journal1997,29,6:1
13Prediction of Bone Loss Rate in Healthy Postmenopausal Women显示文摘J. Y. Reginster R. Deroisy J. Collette A. Albert B. Zegels 1997Calcified Tissue International1997,,3:1
14A 2-year phase ]l study with 1-year of follow-up of risedmnate (NE-58095) in postmenopausal osteoporosis 显示文摘Clemmesen B Ravn P Zegels B 1997Osteoporosis Int1997,7,5:1
15Symptom and structure modifying properties of chondroitin sulfate in osteoarthritis 显示文摘Reginster JY Heraud F Zegels B 2007Mini Rev Med Chem2007,7,10:1
16Percutancous nephroetomy: comparison of sonographic and fluoroscopic guidance 显示文摘Zegel HG Pollack HM Banner MC 1981AIR1981,137,5:1
17Rapid pro- totyping compliant arterial phantoms for in - vitro studies and de- vice testing显示文摘BIGLINO G VERSCHUEREN P ZEGELS R 2013J Cardiovasc Magn Reson2013,15,:1
18A 2-year phase II study with 1 - year of follow-up of risedronate ( NE - 58095 ) in postmenopausal os- teoporosis显示文摘Clemmesen B Ravn P Zegels B 1997Osteoporos Int1997,7,:1
19A 2-year phaseⅡstudy with 1-year of follow-up of risedronate(NE-58095)in postmenopausal osteopo-rosis显示文摘Clemmesen B Ravn P Zegels B 1997Osteoporos Int1997,7,7:1
20Qualitative properties of two-dimensional predator-prey systems显示文摘Kooij R E Zegeling A 1997Nonlinear Analysis Theory Methods and Applications1997,29,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费